In summary, we propose RECK as a diagnostic marker for RCC and the subtypes of RCC suggesting that RECK decrease is an early step in tumorigenesis, whereas EMMPRIN as a prognostic marker is a later event associated with increasing aggressiveness. The gene discussed is BSG; the disease is renal cell carcinoma.